Back
Calamos Convertible Equity Alt ETF Vs. Neurogene Industry Stock Comparison
Buy
61
CVRT
Calamos Convertible Equity Alt ETF
Last Price:
28.87
Seasonality Move:
16.09%
Buy
75
NGNE
Neurogene
Last Price:
64.32
Seasonality Move:
58.98%
Buy
61
Calamos Convertible Equity Alt ETF (CVRT)
is a Buy
Is Calamos Convertible Equity Alt ETF a Buy, Sell or Hold?
- The current Calamos Convertible Equity Alt ETF [CVRT] share price is $28.93. The Score for CVRT is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- CVRT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Neurogene (NGNE)
is a Buy
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $66.00. The Score for NGNE is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- NGNE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CVRT Stock Price Chart
What is Calamos Convertible Equity Alt ETF's stock price today?
-
The Calamos Convertible Equity Alt ETF share price today is $28.93
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CVRT is experiencing buying pressure, which is a positive indicator for future bullish movement.
CVRT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 56.01 | Buy |
| Chaikin Money Flow: | 1336 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.53 - 29.13) | Buy |
| Bollinger Bands (100): | (26.79 - 28.57) | Buy |
NGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.06 | Buy |
| Relative Strength Index (14 RSI): | 75.97 | Buy |
| Chaikin Money Flow: | 176225 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
CVRT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.8 | Buy |
| 20-day SMA: | 28.94 | Sell |
| 50-day SMA: | 28.3 | Buy |
| 200-day SMA: | 27.34 | Buy |
| 8-day EMA: | 28.79 | Buy |
| 20-day EMA: | 28.77 | Buy |
| 50-day EMA: | 28.39 | Buy |
| 200-day EMA: | 27.22 | Buy |
NGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.43 | Buy |
| 20-day SMA: | 49.56 | Buy |
| 50-day SMA: | 43.32 | Buy |
| 200-day SMA: | 37.93 | Buy |
| 8-day EMA: | 50.65 | Buy |
| 20-day EMA: | 48.54 | Buy |
| 50-day EMA: | 44.96 | Buy |
| 200-day EMA: | 36.96 | Buy |
Calamos Convertible Equity Alt ETF Earnings Growth & CVRT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.11 per share.
Calamos Convertible Equity Alt ETF Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurogene Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||